Xalkori

Product NDC
0069-0251
11-digit product format
000690251
Labeler code
0069
Product ID
0069-0251_f5e01d3a-43fc-4fa6-b5dd-a07330b49328
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
CRIZOTINIB
Dosage form
CAPSULE, COATED PELLETS
Route
ORAL
Labeler
Pfizer Laboratories Div Pfizer Inc
Application
NDA217581
Marketing category
NDA
Marketing start
2023-11-20
Substance
CRIZOTINIB
Active strength
20 mg/1
Pharmacologic classes
Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Organic Cation Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Receptor Tyrosine Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Xalkori
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CRIZOTINIB20 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii53AH36668S
Rxcui1148498, 1148502, 1148504, 1148506, 2670166, 2670170, 2670172, 2670174, 2670176, 2670178

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f170fd86-ec78-ad31-9645-3b581b85a0f1Product name220250620

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0069-0251-60Xalkori60 in 1 BOTTLECAPSULE, COATED PELLETS6046

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0069-0251-60EA - Each0069-0251c214720e-304d-47f3-b127-1c527d3cc2a612023-12-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CRIZOTINIBACTIVE INGREDIENT53AH36668SXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
CRIZOTINIBACTIVE MOIETY53AH36668SXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
AMMONIAINACTIVE INGREDIENT5138Q19F1XXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675XALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357XALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
GELATININACTIVE INGREDIENT2G86QN327LXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30XALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3XALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
SHELLACINACTIVE INGREDIENT46N107B71OXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4XALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPXALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]21

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0069-0251XALKORI (CRIZOTINIB) CAPSULE XALKORI (CRIZOTINIB) CAPSULE, COATED PELLETS [PFIZER LABORATORIES DIV PFIZER INC]45Current NDC, 1 package rows20250109_2a51b0de-47d6-455e-a94c-d2c737b04ff7.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2670166crizotinib 150 MG Oral PelletPSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670172crizotinib 20 MG Oral PelletPSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148498crizotinib 200 MG Oral CapsulePSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148504crizotinib 250 MG Oral CapsulePSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670176crizotinib 50 MG Oral PelletPSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670170XALKORI 150 MG Oral PelletPSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670174XALKORI 20 MG Oral PelletPSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148502Xalkori 200 MG Oral CapsulePSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148506Xalkori 250 MG Oral CapsulePSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670178XALKORI 50 MG Oral PelletPSN2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670170crizotinib 150 MG Oral Pellet [Xalkori]SBD2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670174crizotinib 20 MG Oral Pellet [Xalkori]SBD2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148502crizotinib 200 MG Oral Capsule [Xalkori]SBD2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148506crizotinib 250 MG Oral Capsule [Xalkori]SBD2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670178crizotinib 50 MG Oral Pellet [Xalkori]SBD2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670166crizotinib 150 MG Oral PelletSCD2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670172crizotinib 20 MG Oral PelletSCD2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148498crizotinib 200 MG Oral CapsuleSCD2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148504crizotinib 250 MG Oral CapsuleSCD2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670176crizotinib 50 MG Oral PelletSCD2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670170Xalkori 150 MG Oral PelletSY2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670174Xalkori 20 MG Oral PelletSY2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148502Xalkori 200 MG Oral CapsuleSY2a51b0de-47d6-455e-a94c-d2c737b04ff746
1148506Xalkori 250 MG Oral CapsuleSY2a51b0de-47d6-455e-a94c-d2c737b04ff746
2670178Xalkori 50 MG Oral PelletSY2a51b0de-47d6-455e-a94c-d2c737b04ff746

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0069-0251-600006902516060 CAPSULE, COATED PELLETS in 1 BOTTLE (0069-0251-60) 2023-11-20NoNoCurrent